Does TREPROSTINIL Cause Hypokalaemia? 196 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 196 reports of Hypokalaemia have been filed in association with TREPROSTINIL (TYVASO). This represents 0.2% of all adverse event reports for TREPROSTINIL.
196
Reports of Hypokalaemia with TREPROSTINIL
0.2%
of all TREPROSTINIL reports
19
Deaths
168
Hospitalizations
How Dangerous Is Hypokalaemia From TREPROSTINIL?
Of the 196 reports, 19 (9.7%) resulted in death, 168 (85.7%) required hospitalization, and 16 (8.2%) were considered life-threatening.
Is Hypokalaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TREPROSTINIL. However, 196 reports have been filed with the FAERS database.
What Other Side Effects Does TREPROSTINIL Cause?
Dyspnoea (16,348)
Headache (14,051)
Diarrhoea (11,335)
Nausea (10,320)
Cough (8,945)
Fatigue (7,440)
Dizziness (7,405)
Infusion site pain (5,169)
Vomiting (5,097)
Death (4,764)
What Other Drugs Cause Hypokalaemia?
FUROSEMIDE (2,503)
HYDROCHLOROTHIAZIDE (1,152)
CARBOPLATIN (1,118)
PREDNISONE (967)
DEXAMETHASONE (876)
CYCLOPHOSPHAMIDE (864)
OMEPRAZOLE (851)
RITUXIMAB (822)
AMLODIPINE (815)
PANTOPRAZOLE (811)
Which TREPROSTINIL Alternatives Have Lower Hypokalaemia Risk?
TREPROSTINIL vs TREPROSTINIL DIOLAMINE
TREPROSTINIL vs TRETINOIN
TREPROSTINIL vs TRIAMCINOLONE
TREPROSTINIL vs TRIAMCINOLONE ACETONIDE
TREPROSTINIL vs TRIAMCINOLONE HEXACETONIDE